Double seropositive myasthenia gravis with acetylcholine receptor and lipoprotein receptor-related protein 4 antibodies

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F14%3A00061139" target="_blank" >RIV/00159816:_____/14:00061139 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1002/mus.24166" target="_blank" >http://dx.doi.org/10.1002/mus.24166</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/mus.24166" target="_blank" >10.1002/mus.24166</a>

Result language
angličtina
Original language name
Double seropositive myasthenia gravis with acetylcholine receptor and lipoprotein receptor-related protein 4 antibodies
Original language description
Low density receptor-related protein 4 (LRP4), has been recognized recently as a novel antigen implicated in the pathogenesis of myasthenia gravis (MG).1-4 Patients who harbor antibodies directed to LRP4 comprise a distinct subgroup of seronegative MG patients whose clinical phenotype has not yet been characterized well. Among the 4 available studies, the percentage of LRP4 positive patients within the seronegative group varied from 2% to 46%.1
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FH - Neurology, neuro-surgery, nuero-sciences
OECD FORD branch
—

Project
<a href="/en/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: St. Anne´s University Hospital Brno - International Clinical Research Center (FNUSA-ICRC)</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)